Visiontree®, a leader in cloud-based, patient-reported outcomes, patient engagement and multi-center research/registry solutions, is pleased to announce its participation at the 'ESTRO 35' conference in Turin, Italy, April 29 - May 3, 2016.
Visiontree will be demonstrating its Visiontree Optimal Care™ (VTOC) v5.0 platform, as a proven, robust oncology solution for patient-reported outcomes, research/registry initiatives and Meaningful Use workflow optimization. The VTOC patient portal is ARRA HITECH certified for Meaningful Use Stages 1 and 2, interoperable with any HIS or OIS for your free-standing cancer center or integrated with your hospital enterprise.
VTOC features highlighted at the meeting include:
Implemented at 600+ sites, including 400+ oncology programs and 8 of 10 U.S. & World Report Hospitals, in 12+ countries with 2.5M+ patient users, VTOC has delivered the following proven results:
To schedule a one-on-one demo/meeting at 'ESTRO 35' with the Visiontree team, please contact us at: email@example.com
To learn more about how VTOC can improve your compliance for collecting patient reported outcomes, multi-center research/registry initiatives, integrated Meaningful Use and population health solutions, please visit us at: www.visiontree.com, or set-up a specific webinar time for your organization at: firstname.lastname@example.org
Visiontree Software, Inc., a Brainlab company, is a leader in cloud-based, patient-centered health electronic medical records, communication and population health data management systems. The Visiontree Optimal Care (VTOC) outcomes platform is MACRA compliant as a modular EHR and implemented at over 600 sites with 2.5M+ patient records in 15+ languages.
The VTOC platform is used for multi-center research, registries and population health initiatives across multiple domains. Visiontree's customer base consists of leading academic and community centers, research organizations and medical societies globally including 17 of the top 20 U.S. News and World Report hospitals.